Condensed Consolidated Statement of Operations (Unaudited) - USD ($)		3 Months Ended
		Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Revenue		$ 2,485,204	$ 16,914
Cost of Goods Sold		(1,060,908)	(6,938)
Gross Profit		1,424,296	9,976
Operating Expenses
Research and development	[1]	288,473	311
Sales and marketing	[1]	14,054	2,159
General and administrative	[1]	4,433,443	803,711
Depreciation and amortization		2,832,152	233,228
Total Operating Expenses		7,568,122	1,039,409
Net Operating Loss		(6,143,826)	(1,029,433)
Other Income (Expense)
Loss on investment		(24)
Foreign currency transaction gain		90,818
Interest expense		(973,169)	(31,234)
Gain on the sale of assets		663
Total Other Expenses		(881,712)	(31,234)
Net Loss Before Income Taxes		(7,025,538)	(1,060,667)
Deferred Tax Benefit			289,990
Net Loss		$ (7,025,538)	$ (770,677)
Loss per common share:
Basic		$ (0.05)	$ (0.03)
Diluted		$ (0.05)	$ (0.03)
Weighted-average shares outstanding:
Basic		128,365,109	28,065,385
Diluted		128,365,109	28,065,385

[1] These are exclusive of depreciation and amortization